YUTREPIA: A New FDA Approved Treatment for PAH & PH-ILD
I’m Aware That I’m Rare: the phaware® podcast
Episode 523 - Rodolfo Estrada, MD
Dr. Rodolfo Estrada, is a seasoned pulmonologists currently at UT Health San Antonio with significant experience in the management of patients with different forms of pulmonary hypertension. In this episode Dr. Estrada will discuss the technology and clinical development behind YUTREPIA™ (treprostinil) inhalation powder and why it might be a good option for some PAH and PH-ILD patients.
The Evolution of Inhaled Therapies: PRINT® Technology
I’m Aware That I’m Rare: the phaware® podcast
Episode 520 - Seth Hall, MBA, RRT
Seth Hall, MBA, RRT, takes listeners on a journey through the past, present, and future of inhaled therapies. Discover how these treatments have evolved, the life-changing benefits they offer, and the revolutionary technologies that could redefine outcomes for PAH and PH-ILD patients.